Press "Enter" to skip to content

New patent expiration for Leo Labs drug PICATO

4
Copyright © DrugPatentWatch. Originally published at New patent expiration for Leo Labs drug PICATO

Annual Drug Patent Expirations for PICATO
Annual Drug Patent Expirations for PICATO

Picato is a drug marketed by Leo Labs and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug and one Paragraph IV challenge.

PICATO drug price trends.

Drug patent litigation for PICATO.

This drug has forty-eight patent family members in twenty-five countries.

The generic ingredient in PICATO is ingenol mebutate. One supplier is listed for this compound. Additional details are available on the ingenol mebutate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Leo Labs drug PICATO
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions